312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate
The Readout Loud
Innovations in AI and Drug Discovery in Healthcare
Discussion on AI startup Celerity's use of computational methods to study cell progression and drug impact, Basecamp's unique focus on enzymes for drug discovery, and Al Nylum's promising phase three trial results for Vutri in treating ATTR-CM heart condition.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
